Business Wire

NATECH

21.3.2024 10:01:29 CET | Business Wire | Press release

Share
Natech Launches Next Stage of Mission to Democratize Access to Technology for All Financial Institutions

Natech Banking Solutions, provider of a leading end-to-end digital banking platform, has today announced a rebrand that sets a foundation for the next generation of its product suite, which democratizes access to cutting-edge financial technology.

The complete and comprehensive Natech platform guarantees Tier-1 functionality to local and regional banks seeking modernization, enabling ambitious institutions with limited budgets to drive growth, gain a competitive edge, and increase market share.

The new brand identity signifies Natech’s focus on global expansion and the evolution of its product offering to empower financial institutions including fintechs and neobanks around the world with accessible, resilient digital banking technology.

Last year, Natech successfully concluded its first funding round, securing €10 million to fuel strategic European expansion initiatives and advance the development of Snappi — a joint venture with Piraeus Financial Holdings with the mission of providing an independent, branchless, and digital-only bank serving Europe. After launching, Snappi will operate as a ground-breaking institution for Banking-as-a-Service across Europe.

Headquartered at a fast-growing high-tech hub for Southern Europe in Ioannina, Greece, Natech has grown its operations worldwide to build a diverse and growing network of partners and clients across 40 countries including Snappi, Bank of Karditsa, Ziraat Bank, OPAP, Cooperative Bank of Epirus and many more.

Thanasis Navrozoglou, Group CEO, said: “We are committed to empowering financial institutions by enabling them to access and leverage the latest technology. The rebrand marks the beginning of the next stage of Natech’s journey, which will focus on global growth. It is our mission to craft advanced banking solutions that are accessible to any financial institution, regardless of size or R&D budget, and we are committed to helping new and existing clients deliver extraordinary banking experiences. Thanks to all our amazing customers, partners, team members, and everyone else who has worked with us to make the last 20 years so successful.”

About Natech Banking Solutions

Natech Banking Solutions democratizes access to banking technology and liberates resources, allowing financial institutions to prioritize what's most important — outstanding service and customer fulfillment.

Its comprehensive product suite, encompassing everything from a core banking system to digital engagement channels, enables banks to craft and deliver personalized financial products.

Catering to a diverse clientele that ranges from credit unions and local community banks to forward-thinking regional financial institutions and digital challenger banks, Natech’s platform offers fast, seamless, and straightforward onboarding to accelerate time-to-market.

With roots in Greece, Natech has a global footprint, a presence in strategic locations across Europe, and a network of regional and international partners.

www.natechbanking.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240320116993/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Celltrion Expands Omlyclo® Portfolio in Europe with Launch of 300 mg Strength25.8.2026 00:40:00 CEST | Press release

Omlyclo® (omalizumab) 300 mg launched in key European markets including Germany, the UK and France, with rollout to expand across Europe by year-endOmlyclo® 300 mg strength available in both pre-filled syringe (PFS) and autoinjector (AI) presentationsMultiple dose strengths and device options broaden treatment flexibility for healthcare professionals Celltrion (KRX: 068270) today announced the launch of the 300 mg strength of Omlyclo® (omalizumab), a treatment for chronic spontaneous urticaria and allergic asthma, in Europe.1 With the addition of the 300 mg strength, Celltrion has expanded its Omlyclo® portfolio to include multiple dose strengths and device presentations for patients, healthcare professionals and healthcare institutions. Following the European launch of Omlyclo® 75 mg and 150 mg late last year, Celltrion began rolling out the 300 mg strength in key markets including Germany, the UK and France in the middle of this year. Celltrion is gradually expanding supply to other

Fourthline Trust Services Granted Status as Qualified Trust Service Provider in the EU24.8.2026 15:13:00 CEST | Press release

QTSP status allows for full control over the digital trust value chain from identity verification to qualified electronic signature (QES) issuance Fourthline Trust Services AB, a subsidiary of Fourthline, has been granted qualified status under the EU's eIDAS Regulation (910/2014)¹ and is now listed on the EU Trusted List as a Qualified Trust Service Provider (QTSP). Supervised by the Swedish Post and Telecom Authority (Post- och telestyrelsen, PTS), Fourthline Trust Services AB issues qualified certificates for electronic signatures. Fourthline, is the leading European provider of AI-powered identity verification (IDV) and compliance solutions. This milestone allows Fourthline full control over the entire digital trust value chain from identity verification to qualified electronic signature (QES) issuance. Ralph Post, Fourthline Trust Services AB Board Member: "By building our QTSP infrastructure similar to our sovereign AI-powered platform that drives our industry-leading identity ve

SLB Launches ExaCT Electrical Downhole CT Control System24.8.2026 13:02:00 CEST | Press release

New platform brings real-time electrical control to coiled tubing intervention, enabling greater precision, visibility and efficiency across intervention operations SLB (NYSE: SLB) today launched the ExaCT™ electrical downhole coiled tubing (CT) control system, an advanced intervention platform that introduces real-time electrical control to coiled tubing operations. By replacing pressure-dependent hydraulic actuation with electrical communication, power delivery and telemetry, the ExaCT system gives operators greater visibility, precision and control, helping improve intervention execution and reservoir access. The ExaCT system combines electrical power, telemetry and downhole measurements to enable communication with, actuation of and verification of downhole tools throughout an intervention. Continuous communication across the toolstring enables on-demand tool actuation across a wide range of intervention applications, including extended-reach and multilateral wells. The increased p

Wolters Kluwer Transforms Trusted Legal Content Into Structured, AI-Ready Intelligence That Powers the Next Wave of Legal AI24.8.2026 13:01:00 CEST | Press release

By transforming authoritative legal content into structured legal intelligence, Wolters Kluwer gives AI the context and relationships needed to deliver deeper research and higher-quality results Wolters KluwerLegal & Regulatory today announced the next evolution of Libra by Wolters Kluwer, its all-in-one Legal AI Workspace. By transforming authoritative legal sources, expert commentaries, and practical guidance into structured legal intelligence, Wolters Kluwer is making the relationships across the full breadth of its expert legal sources more explicit. This will enable deeper contextual research, more comprehensible answers, and workflow-ready results across legal work. Following the integration of Wolters Kluwer content into the Libra AI workspace in the first half of 2026, laws, rulings, expert commentaries, and practical guidance will now be linked to one another and to the matter at hand, creating a connected knowledge graph of expert-curated and authoredlegal knowledge that AI c

Daiichi Sankyo Appoints Markus Kosch to Lead Europe Business as Part of New Commercialization Organization24.8.2026 10:00:00 CEST | Press release

Daiichi Sankyo (TSE: 4568) today announced the appointment of Markus Kosch, MD, as Head of Europe Business, effective April 1, 2027. In this role, he will lead the company's European business within the new globally integrated Commercialization Unit and serve as General Manager of Daiichi Sankyo Europe GmbH, with legal responsibility for the company in Europe. The appointment reflects the next phase of growth of Daiichi Sankyo under its Five-Year Business Plan and the establishment of a new Commercialization Unit. Within this new structure, Markus Kosch will bring together the Oncology and Specialty businesses in Europe under one integrated leadership model to help bring innovative medicines to more patients across the region. For the past five years, Markus Kosch has led the Daiichi Sankyo Oncology Business Division in Europe and Canada, overseeing a period of significant growth and preparing the organization for an increasingly expanding oncology portfolio. Prior to joining Daiichi S

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye